A Study of PRA023 in Healthy Volunteers
Clinical trial NCT04676178 · COMPLETED
Trial details
- NCT number
- NCT04676178
- Sponsor
- Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2021-09-23
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.